Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 8/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.30 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
| ▸ | HRH1 | P35367 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20051820 | 0.86 | TSHR (0.33) | TSHR | |
| SCHEMBL20033533 | 0.83 | DNM1 (0.46) | DNM1ALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL1165074 | 0.81 | DNM1 (0.50) | DNM1ALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL13108938 | 0.80 | CPB2 (0.34) | CPB2 | |
| SCHEMBL28818806 | 0.80 | DNM1 (0.31) | DNM1ALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL6942427 | 0.80 | TSHR (0.40) | TSHR | |
| SCHEMBL379681 | 0.78 | CYP3A4 (0.31) | CYP3A4 | |
| SCHEMBL11496837 | 0.78 | CA2 (0.42) | DNM1ALDH1A1TSHRCYP3A4TDP1 | |
| Ammonia Solution, Strong SCHEMBL4436488 | 0.77 | — | — | |
| Hydrazine SCHEMBL21526745 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170260174-A1 | Benzene, Pyridine, and Pyridazine Derivatives | ESANEX INC (US) | 2017-09-14 | — | — | US | disclosed |
| EP-0669314-A1 | Process for preparing substituted cis-cyclohexylamines | Hoechst Schering AgrEvo GmbH (DE) | 1995-08-30 | — | — | EP | disclosed |
| US-4122264-A | Pyridine containing morpholines | THE UPJOHN COMPANY (US) | 1978-10-24 | — | — | US | disclosed |
| US-4115396-A | HYPOTENSIVE AGENTS | THE UPJOHN COMPANY (US) | 1978-09-19 | — | — | US | disclosed |
| US-4089672-A | HERBICIDES | THE UPJOHN COMPANY (US) | 1978-05-16 | — | — | US | disclosed |
| US-4084955-A | 1-CARBOXYALKYL-DI- AND TRIHALOPYRAZOLES, HERBICIDES | THE UPJOHN COMPANY (US) | 1978-04-18 | — | — | US | disclosed |
| US-4067874-A | Novel pyridine 1-oxides | THE UPJOHN COMPANY (US) | 1978-01-10 | — | — | US | disclosed |
| US-3995035-A | 6-Amino-2-lower-alkyl-4-nitropyridine N-oxide compositions and coccidiostat process | THE UPJOHN COMPANY (US) | 1976-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170260174-A1 | Benzene, Pyridine, and Pyridazine Derivatives | CDK4, P2RX4, MKI67 | DNM1 3843/4885ALDH1A1 1049/4885TSHR 1413/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.